RxDoctor Payments Data

Analise Douglas, MD

Interventional Cardiology · Jackson, MSNPI 1396279451

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.7% of the total across 115 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by Abiomed at 24.2% of the total. 2025 is the largest year on record at $1,361, 9.2 times the $148 reported in 2022. That places this record below the midpoint for interventional cardiology clinicians in MS, where the typical reported total is $7,952.

$3,456in general payments, 2019–2025

Across 115 payments — averaging $30.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$835
  • Boston Scientific$356
  • Abbott$237
  • E.r. Squibb & Sons, L.L.C.$202
  • Medtronic$176
  • W. L. Gore & Associates, Inc.$167
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$3,13691%
  • Education$3209%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,456 in reported general payments places this provider in the 15th percentile of 65 interventional cardiology providers in Mississippi.

See all interventional cardiology providers in Mississippi

Medicare billing

Part B allowed, 2024
$68,728
Medicare patients
138
Services billed
833

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Rosuvastatin Calcium11$160
Atorvastatin Calcium23$142
Potassium Chloride13$121
Furosemide19$56
Metoprolol Tartrate11$56

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →